Patent Selections | Bentham Science

Register Cart 0

Generic placeholder image

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)

Editor-in-Chief

ISSN (Print): 1872-2148
ISSN (Online): 2212-3334

Back Subscribe

Patent Selections

Author(s): Bentham Science Publishers

Volume 1, Issue 3, 2007

Page: [255 - 257] Pages: 3

DOI: 10.2174/187221407782409134

Price: $65

Open Access Journals Promotions 2

Abstract

« Previous

Rights & Permissions Print Cite

Article Metrics

2

Related Articles

Exploiting Protein Phosphatase Inhibitors Based on Cantharidin Analogues for Cancer Drug Discovery
Mini-Reviews in Medicinal Chemistry

Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy
Current Pharmaceutical Design

Tissue Elasticity Bridges Cancer Stem Cells to the Tumor Microenvironment Through microRNAs: Implications for a “Watch-and-Wait” Approach to Cancer
Current Stem Cell Research & Therapy

The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
Current Cancer Drug Targets

Clozapine and COVID-19: A Case Report and Clinical Considerations
Current Drug Safety

Targeting Glioblastoma Stem Cells: Cell Surface Markers
Current Medicinal Chemistry

Mitochondria Damage in the Pathogenesis of Diabetic Retinopathy and in the Metabolic Memory Associated with its Continued Progression
Current Medicinal Chemistry

Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?
Cardiovascular & Hematological Agents in Medicinal Chemistry

Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19
Current Drug Targets

Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)

Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression
Recent Patents on Anti-Cancer Drug Discovery

<i>In Silico</i> Approach to Predict the SARS-COV2 Derived Candidate MiRNAs as a Potential Antiviral Therapy
Current Drug Therapy

ROS Modulate Cell Death Mechanism in Cervical Cancer Cells Treated with the Combination of Polyphenolic Compounds and Anticancer Drug Cisplatin: A Review
Current Cancer Therapy Reviews

Synthesis and Studies of Anticancer and Antimicrobial Activity of New Phenylurenyl Chalcone Derivatives
Letters in Drug Design & Discovery

Gemcitabine Resistance is Associated with Epithelial-Mesenchymal Transition and Induction of HIF-1α in Pancreatic Cancer Cells
Current Cancer Drug Targets

Synthesis and Biological Evaluation of Arylpiperazine Derivatives as Anticancer Agents
Letters in Organic Chemistry

Radiovirotherapy: Principles and Prospects in Oncology
Current Pharmaceutical Design

The Biological Functions of NF-κB1 (p ) and its Potential as an Anti-Cancer Target
Current Cancer Drug Targets

HSP60 as a Drug Target
Current Pharmaceutical Design

[6]-gingerol as a Cancer Chemopreventive Agent: A Review of Its Activity on Different Steps of the Metastatic Process
Mini-Reviews in Medicinal Chemistry

© 2024 Bentham Science Publishers | Privacy Policy